about
Coronary heart disease and hormone replacement therapy after the menopauseQuestioning the benefits of statinsThe benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trialsShould women be offered cholesterol lowering drugs to prevent cardiovascular disease? NoThe effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientistsMuscular effects of statins in the elderly female: a reviewPostmenopausal hormones and coronary artery disease: potential benefits and risksPattern of statin use in southern italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?Cardiovascular Disease in Women: Clinical Perspectives.Influences of age, sex, and LDL-C change on cardiovascular risk reduction with pravastatin treatment in elderly Japanese patients: A post hoc analysis of data from the Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE)Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.In Perspective: Estrogen Therapy Proves to Safely and Effectively Reduce Total Mortality and Coronary Heart Disease in Recently Postmenopausal WomenSex differences in type 2 diabetes: focus on disease course and outcomesDifferences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study.A comprehensive view of sex-specific issues related to cardiovascular disease.A "window of opportunity:" the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent.Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of CardiologyDifferential impact of statin on new-onset diabetes in different age groups: a population-based case-control study in women from an asian countryNo connection between the level of exposition to statins in the population and the incidence/mortality of acute myocardial infarction: an ecological study based on Sweden's municipalitiesJUPITER and satellites: Clinical implications of the JUPITER study and its secondary analyses.Endothelial function in women of the Kronos Early Estrogen Prevention Study.Sex differences in the effectiveness of statins after myocardial infarction.Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating RosuvastatiStatin use after acute myocardial infarction: a nationwide study in DenmarkCardiovascular disease and primary ovarian insufficiency.Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspectivePrevalence of polypharmacy and drug interaction among hospitalized patients: opportunities and responsabilities in pharmaceutical careAsymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase.Benefit/risk ratio of statins in primary prevention.The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 1: comparison of therapeutic efficacy.Incident coronary artery calcium among postmenopausal women.Problems and possible solutions for therapy with statins.Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women.Women and statin use: a women's health advocacy perspective.Cholesterol lowering, sudden cardiac death and mortality.Premenopausal risk factors for coronary and aortic calcification: a 20-year follow-up in the healthy women study.Postmenopausal hormone therapy and cardiovascular disease in perspective.
P2860
Q22248005-9ECADC0C-7E46-46BF-9C9D-DF874FFF4B29Q24537171-86A15C44-8CB1-49EA-A4E7-AC74994C7BD5Q24646234-C2F72F7B-6543-4263-B0E3-74F4C203C76BQ24685822-DA97AD49-4A5C-4998-B650-4C30B27A21D1Q24793837-C5EEBFC9-2038-41E4-8784-81FFD244F78DQ26749044-036B9A1D-2A4F-459A-B6B4-9181DA0A3DD1Q27023343-47AC398B-12D3-473A-8297-AA15E71AD804Q28221869-9D6F1C6F-BA36-4102-96B1-356CE86B707CQ28541300-FC74489E-CBA0-44D7-80BF-94A75798FD9AQ30743765-A7F2950E-011C-46F3-A24C-5A7116E1E783Q30787990-EC680057-23D1-4E29-A680-C39F1377E397Q33826605-A51EA537-0B87-4A4A-B73A-0CDD5D4FC2FEQ33862138-BCDE6B4C-C3C5-4F18-80B7-768E0C177BABQ34229975-6CC8EF4C-C0FA-450A-BAB1-2B7D499BB062Q34307460-F2E3C117-DAC4-461D-AF38-6A2B7AD84EBDQ34577461-BB38BE60-B59E-497F-A400-81D4B869DA4BQ34612394-BFEC4844-05B1-4BB0-8BD3-E045A5A955BEQ34682870-A66050AE-3C99-461B-8E33-E1F8ABA477F8Q34950667-3B5E7ADD-FC00-4BFB-B130-5603664EF555Q35081381-10DFEB0A-91B6-4852-8EAC-A05CF40425FDQ35172886-46D983AE-C494-458A-9F71-6E65A83D12D8Q35317556-50E67AE1-3B01-4569-B6E0-195E1BE5FF63Q35607051-DAAAF26C-0BD4-43DE-9571-75D9AEF1740CQ35631575-EF2DDD6C-DF7F-4278-B9C7-49A05D9C60C0Q35827170-639FC393-E866-41B4-A0AD-2FC2AF6C81F3Q35965092-EA41BD16-AA7D-41B9-81F1-2BAC341B475FQ36102162-79DBAE96-1FE5-474E-962E-3F7938C35823Q36484907-C99CFAA6-C6AC-4EAD-B6E9-F5C0BEFC6420Q36781520-3C34825A-1A43-4638-A2CA-D9D3F76CA069Q36787242-D33C6B20-9DEA-4A18-B48E-D7652BB835E3Q36831934-71771B5A-EF01-4B75-BC9D-AAF3D1899FC5Q36835515-729E691A-54D1-4A14-A859-1C16FA8FB12DQ36863876-D3241050-B954-4DB8-A7BD-2D00BD5A22AFQ36960896-3EFFBF21-A768-4A5A-B838-BC60AA7E4845Q37007848-6D758C37-59D1-4C67-900B-B64D07A3AFD0Q37169720-280F7A96-8B1C-4065-9037-931EB7F17E63Q37210045-15269206-93CF-4476-8DE8-EA26CCAE36FBQ37211908-9139F5BE-9A33-4737-81A3-4B986C7AF2F2Q37229119-964FAA02-B1C3-4427-AA20-6253EA7ED2E3Q37234323-5FED401E-7EBD-472D-8C31-EA7A09A3D7A7
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Drug treatment of hyperlipidemia in women.
@ast
Drug treatment of hyperlipidemia in women.
@en
type
label
Drug treatment of hyperlipidemia in women.
@ast
Drug treatment of hyperlipidemia in women.
@en
prefLabel
Drug treatment of hyperlipidemia in women.
@ast
Drug treatment of hyperlipidemia in women.
@en
P356
P1476
Drug treatment of hyperlipidemia in women.
@en
P2093
Judith M E Walsh
P304
P356
10.1001/JAMA.291.18.2243
P407
P577
2004-05-01T00:00:00Z